AbbVie (NYSE: ABBV) has long been known for its immunology drugs like Humira, which at one point was the top-selling drug in ...

Detailed price information for Uber Technologies Inc (UBER-N) from The Globe and Mail including charting and trades.

Lucid posted deeper Q2 losses and cut its 2025 outlook, but strong liquidity and a key Uber deal support long-term growth.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Lucid reports weak Q2 results with revenue miss, widening losses, and poor cash flow. Despite a rally, challenges persist.

Slow-Motion Car Wreck Lucid Group (NASDAQ:LCID) released its second quarter earnings report yesterday, and the results left ...

Lucid Group › Shares of Lucid Group (NASDAQ: LCID) are falling on Wednesday. The luxury electric vehicle (EV) maker's stock ...

Lucid Group reported disappointing second-quarter results, with revenue of $259.4 million, missing analyst estimates of ...

Leading the charge this morning is Smith & Nephew PLC (LSE:SN), up over 11% after the knee- and hip-replacement group ...

US stocks pushed higher on Wednesday amid another batch of corporate earnings and as President Trump's new deadline to impose ...

Glencore Earnings Fall on Lower Coal Prices, Copper Production Challenges The commodities giant said the results reflect lower coal prices and a drop in copper production following operational ...

Rivian and Lucid posted disappointing quarterly earnings on Tuesday and provided a grim outlook for the year as the electric ...